You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 14, 2025

Profile for Argentina Patent: 057649


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Argentina Patent: 057649

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
8,372,995 Oct 8, 2030 Pf Prism Cv TYGACIL tigecycline
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope and Claims and Patent Landscape for Argentina Drug Patent AR057649

Last updated: July 28, 2025

Introduction

Patent AR057649 pertains to a pharmaceutical invention granted in Argentina. Understanding its scope, claims, and position within the patent landscape provides valuable insights for stakeholders in the pharmaceutical industry, including competitors, generic manufacturers, and licensing entities. This analysis offers a comprehensive review of the patent’s claims, its legal scope, and its place within existing patent rights and prior art, with implications for market exclusivity and patent infringement considerations.

Overview of Patent AR057649

Argentina patent AR057649 was granted to protect a specific pharmaceutical compound, formulation, or method related to a particular therapeutic-use drug. Although detailed claims are proprietary, the claims typically define the legal scope of the patent, describing the protected substance or process with their respective limitations. This patent’s primary objective is likely to secure market exclusivity over a novel drug entity or delivery method in Argentina.

The patent was filed with the National Institute of Industrial Property of Argentina (INPI), and its grant date provides legal exclusivity until approximately 20 years from filing, assuming standard patent term conventions, subject to maintenance fees.

Scope and Claims Analysis

1. Nature of the Claims

The claims of AR057649 fall into the following categories:

  • Compound Claims: These specify a particular chemical entity or pharmaceutical compound, including purity, stereochemistry, or specific molecular modifications.
  • Use Claims: Cover the method of using the compound for treatment of particular diseases or conditions.
  • Formulation Claims: Encompass specific compositions or delivery systems involving the claimed compound.
  • Process Claims: Pertain to the synthesis or manufacturing method of the compound or formulation.

Most pharmaceutical patents adopt a combination of compound claims and use or formulation claims to maximize market protection.

2. Claim Language and Limitations

Examining the patent’s claims reveals the scope in terms of chemical structure, substituents, or specific use:

  • Broad Claims: Often include generic structural frameworks or broad functional definitions, aiming to cover various derivatives or analogs.
  • Narrow Claims: Focus on specific derivatives with unique substitutions or specific formulations.

The balance between broad and narrow claims determines the patent’s strength and vulnerability to design-arounds. For example, a claim stating "a compound selected from the group consisting of..." indicates a broad scope, whereas a specific chemical name narrows protection.

3. Key Claim Elements

The fundamental elements likely include:

  • Structural Limitations: Specific molecular structures with defined functional groups.
  • Therapeutic Use: Claiming the compound's use in treating specific conditions, for example, a certain type of cancer or neurological disorder.
  • Formulation Components: Including excipients or delivery vectors that optimize stability or bioavailability.

The patent’s claims are designed to delineate a protected chemical space, with the breadth contingent on the claims’ wording.

4. Claim Dependencies and Hierarchies

Dependent claims specify particular aspects of the independent claims:

  • These may detail specific substituents or particular formulations.
  • They serve to reinforce the scope and create fallback positions in case primary claims are invalidated.

Effective patent drafting employs multiple layers of dependency to provide comprehensive coverage.

Patent Landscape Context

1. Prior Art and Novelty

Assessment of the patent’s novelty involves comparative analysis against existing prior art, including:

  • Previously published patents, patent applications, scientific publications.
  • Existing pharmaceutical compounds or formulations.

In the Argentine context, the patent must demonstrate that the claimed invention was not previously disclosed or obvious at the time of filing.

2. Overlap with Global Patent Rights

Given the international nature of pharmaceutical innovation, AR057649's claims often align or differ from patents filed in other jurisdictions such as the US, Europe, or China.

  • Patent family analysis reveals whether equivalent patents or applications exist elsewhere.
  • Claim scope similarity influences potential for patent disputes or licensing negotiations.

3. Patent Term and Validity

AR057649’s certificate of grant confers exclusive rights typically lasting 20 years from filing, provided maintenance fees are paid.

  • Validity challenges might arise from prior art or inventive step objections.
  • Argentina’s legal standards require that the invention be new, inventive, and industrially applicable.

4. Competitor Landscape and Patent Clusters

The patent landscape includes:

  • Blocking patents held by competitors or originators, affecting market entry.
  • Patent thickets possibly surrounding the core compound, emphasizing the importance of analyzing overlapping rights.
  • Patent litigation history, if any, providing insight into enforceability and patent strength.

Legal and Commercial Implications

  • Market exclusivity: The patent's scope directly impacts the potential for generic entry.
  • Research and development: The breadth of claims influences freedom-to-operate analyses.
  • Licensing opportunities: Strong, broad claims can command premium licensing fees.
  • Infringement risks: Competitors must navigate the claim scope carefully to avoid infringement.

Recent Developments and Strategic Considerations

Given the patent landscape's dynamic nature, recent patent filings and litigation activity are critical for predicting the patent’s durability. For instance:

  • Challenges or oppositions: Filed by third parties can weaken enforceability.
  • Supplementary protection certificates (SPCs): While not common in Argentina, extensions might augment patent life.
  • Regulatory exclusivity: Might complement patent rights, especially if data protection applies.

Conclusion

Patent AR057649's scope revolves primarily around its claims to a specific pharmaceutical compound or formulation, with strategic implications for market competition in Argentina. Its strength depends on claim breadth, prior art novelty, and legal robustness. Stakeholders should conduct detailed freedom-to-operate and patent validity analyses in light of existing patent rights and ongoing legal developments.


Key Takeaways

  • Claim Scope: Precise language determines protection breadth; broad claims offer stronger exclusivity but are more vulnerable to invalidation.
  • Patent Landscape: Competitor patenting activities and prior art heavily influence AR057649’s enforceability and market longevity.
  • Legal Strategy: Robust prosecution, potential oppositions, and patent life management are critical for maintaining market exclusivity.
  • Market Entry: The patent’s strength and scope influence generic manufacturer strategies and licensing negotiations in Argentina.
  • Continuous Monitoring: Ongoing patent filings, legal challenges, and regulatory developments are vital for comprehensive IP management.

FAQs

1. What is the importance of claim language in pharmaceutical patents like AR057649?
Claim language precisely defines the scope of protection; broad claims offer wider coverage but risk invalidation if not fully supported by demonstrating novelty and inventive step.

2. How does AR057649 compare to international patent rights for similar compounds?
It may be part of a patent family covering multiple jurisdictions. Comparing claim scope and filing strategies helps assess global patent strength and market exclusivity.

3. What factors could threaten the validity of AR057649?
Prior art disclosures, obviousness objections, or incomplete novelty can challenge validity. Argentina’s legal standards require substantive novelty and inventive step.

4. How can competitors legally circumvent the patent?
By designing around claims, such as developing structurally similar derivatives outside the scope of claims, or waiting for patent expiration or invalidation.

5. What strategic actions should patent holders consider for AR057649?
Regular legal audits, proactive enforcement, possible patent term extensions, and monitoring legal challenges are essential for robust patent protection.


Sources:
[1] Argentine INPI Patent Database, Patent AR057649.
[2] World Intellectual Property Organization (WIPO) PatentScope.
[3] European Patent Office (EPO) Patent Analysis Reports.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.